Azosemide
Azosemide, a sulfonamide loop diuretic, is a potent NKCC1 inhibitor with IC50s of 0.246 μM and 0.197 μM for hNKCC1A and NKCC1B, respectively[1].
Product Specifications
CAS Number
27589-33-9
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
NKCC
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/azosemide.html
Purity
99.85
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
ClC1=CC(NCC2=CC=CS2)=C(C3=NN=NN3)C=C1S(N)(=O)=O
Molecular Formula
C12H11ClN6O2S2
Molecular Weight
370.84
Precautions
H302, H315, H319, H335
References & Citations
[1]Hampel P, et al. Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B. Sci Rep. 2018 Jun 29;8 (1) :9877.|[2]Kim EJ, et al. Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagaseanalbuminemic rats. Drug Metab Dispos. 2003 Feb;31 (2) :194-201.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 4
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP54092PU-N 400 µL
Syntaxin 5A (STX5) (Center) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
